Health
COVID-19 rapid antibody test receives CE mark and mass production begins – News-Medical.Net
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.

The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark. This means it is approved for professional use in the UK and EU.
This milestone means the rapid test, for detection of IgG antibodies to the SARS-CoV-2 virus (COVID-19) is now available for distribution for professional use. It will be mass produced and tests will be rolled out from the end of August. The test can be administere…
-
Noosa News22 hours ago
Woman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News21 hours ago
Working for someone else made it hard to care for my daughter. So I quit
-
General17 hours ago
‘Potential’ hacker contacts Qantas over data breach
-
Noosa News24 hours ago
Star Entertainment faces $36.5m blow if Queen’s Wharf deal flops